New Biological Drugs & Technologies

DRUG DISCOVERY ‘15
TELFORD INTERNATIONAL
CONFERENCE CENTRE
2ND - 3RD SEPTEMBER 2015
www.elrig.org
#ELRIGDD15
NEW BIOLOGICAL DRUGS & TECHNOLOGIES
Thursday September 3rd
Room: Wenlock
The continuing success of biological drugs, in particular monoclonal antibodies but increasingly also other
modalities such as peptides, conjugates and multi-selective agents, will be considered in this session. Alongside
this, technologies for discovering, optimising and characterising biopharmaceuticals will be discussed. The session
will also explore the interface between biological and small molecule drugs: can information from biological drugs
help us design better small molecule drugs? how are drugs at the interface of both areas, such as cyclic peptides
and small molecule conjugates to peptides, proteins and antibodies, defining novel drug classes?
CHAIRS: Katy Kettleborough, MRC Technology. Dr. Lutz Jermutus, MedImmune
TIME
9:10 - 9:15
SPEAKER
Session Chairs
TITLE
Introduction and Welcome
9:15 - 10:00
Keynote Speaker: Philipp Holliger
MRC Laboratory of Molecular Biology
Towards a New Class of Biotherapeutics Based on
Synthetic Genetic Polymers
10:00 - 10:30
Dan Teufel
Bicycle Therapeutics
Development of Cytotoxic Bicyclic Peptide Drug
Conjugates and Applications in Molecular Targeted Cancer
Therapy
10:30 - 11:00 COFFEE
11:00 - 11:30 Tom Crabbe
UCB
How Information From the Study of Antibody Function
Can be Used in the Discovery of Novel Small Molecule
Therapeutics
11:30 - 12:00 POSTER
12:00 - 12:30 SNAPSHOT
12:30 - 14:00 LUNCH - EXHIBITION PLENARY KEYNOTE: ROOM - IRONBRIDGE
14:00 - 15:00 Professor Tracy Hussell
The Development of New Therapeutics for respiratory
inflammation
Manchester Collaborative Centre for
Inflammation Research
15:00 - 15:30 Volker Schellenberger
Amunix
XTEN Protein Polymer for Half-Life Extension and
Tumor Drug Delivery
15:30 - 16:00 Bent Jakobsen
Adaptimmune
Fine-Tuned T Cell Receptors for Cancer Immunotherapy
16:00 - 16:30 John Hartley
University College London
PBD-Based Antibody Drug Conjugates
16:30 - 17:00 CLOSE OF CONFERENCE - with prize